source
- FDA rejects Capricor's Duchenne cell therapy citing serious data integrity violationsThe Food and Drug Administration issued a second rejection of Capricor Therapeutics' cell therapy, deramiocel, aimed at treating Duchenne muscular dystrophy. The agency said the revised application…
- Debate Over Whether Medical School Should Begin After USMLE Step 1 ExamSTAT published an opinion essay proposing that medical school start after students take the Step 1 exam. The piece prompted letters to the editor, with readers offering personal reflections on the…